QU

Quantum Cyber N.V.

QUCYHealthcareNASDAQ

Diagnostics & Research

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$537,080
-39.9% YoY
Net Income
-$16.2M
+24.9% YoY
EBITDA
-$15.2M
+23.7% YoY
Free Cash Flow
-$7.6M

Scan Results

Daily timeframe
DateIndicatorDetails
Jul 31CONFIRMED MACD Positive CrossoverHistogram +0.0084, positive momentum
RSI OversoldRSI 23.4, below 30, stock may be oversold
Jul 30CONFIRMED MACD Positive CrossoverHistogram +0.0028, positive momentum
RSI OversoldRSI 12.2, below 30, stock may be oversold
About Quantum Cyber N.V.

Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The $119.4M market capitalization puts QUCY squarely in micro-cap range for its industry. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies.

Where QUCY stands vs its 150-day and 200-day moving averages

As of the July 31, 2026 close, QUCY finished 5.13% below its 150-day moving average ($1.17) and 7.50% below its 200-day moving average ($1.20). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is QUCY overbought or oversold?

At the July 31, 2026 close, QUCY's RSI(14) was 23.4, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$119.4M
EPS$-2.41
Beta2.37
52W Change-7.6%
ROE-212.5%
Analysis

The balance sheet looks solid with $13.4M in cash comfortably exceeding the $169K debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow is running at -$7.6M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of -212.5% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has been relatively flat, moving from $530K (2022) to $537K (2025).

With a beta above 1.5, QUCY tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Quantum Cyber N.V.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms